Cargando…
Interfocal heterogeneity challenges the clinical usefulness of molecular classification of primary prostate cancer
Prostate cancer is a highly heterogeneous disease and typically multiple distinct cancer foci are present at primary diagnosis. Molecular classification of prostate cancer can potentially aid the precision of diagnosis and treatment. A promising genomic classifier was published by The Cancer Genome...
Autores principales: | Carm, Kristina Totland, Hoff, Andreas M., Bakken, Anne Cathrine, Axcrona, Ulrika, Axcrona, Karol, Lothe, Ragnhild A., Skotheim, Rolf I., Løvf, Marthe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753093/ https://www.ncbi.nlm.nih.gov/pubmed/31537872 http://dx.doi.org/10.1038/s41598-019-49964-7 |
Ejemplares similares
-
High expression of SCHLAP1 in primary prostate cancer is an independent predictor of biochemical recurrence, despite substantial heterogeneity
por: Kidd, Susanne G., et al.
Publicado: (2021) -
In situ expression of ERG protein in the context of tumor heterogeneity identifies prostate cancer patients with inferior prognosis
por: Kidd, Susanne G., et al.
Publicado: (2022) -
Somatic mutations reveal complex metastatic seeding from multifocal primary prostate cancer
por: Carm, Kristina T., et al.
Publicado: (2022) -
Novel transcription-induced fusion RNAs in prostate cancer
por: Zhao, Sen, et al.
Publicado: (2017) -
Novel RNA variants in colorectal cancers
por: Hoff, Andreas M., et al.
Publicado: (2015)